|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
US5846945A
(en)
|
1993-02-16 |
1998-12-08 |
Onyx Pharmaceuticals, Inc. |
Cytopathic viruses for therapy and prophylaxis of neoplasia
|
|
ATE199568T1
(de)
|
1993-02-16 |
2001-03-15 |
Onyx Pharma Inc |
Cytopatische viren zur therapie und prophylaxe der neoplasie
|
|
US7045347B2
(en)
|
1993-06-24 |
2006-05-16 |
Advec, Inc. |
Helper dependent adenovirus vectors based on integrase family site-specific recombinases
|
|
US5543328A
(en)
|
1993-08-13 |
1996-08-06 |
Genetic Therapy, Inc. |
Adenoviruses having modified fiber proteins
|
|
US20010006629A1
(en)
|
1993-10-25 |
2001-07-05 |
Richard J. Gregory |
Recombinant adenoviral vector and methods of use
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
US5559099A
(en)
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
|
US5965541A
(en)
|
1995-11-28 |
1999-10-12 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
|
US5962311A
(en)
|
1994-09-08 |
1999-10-05 |
Genvec, Inc. |
Short-shafted adenoviral fiber and its use
|
|
FR2726285B1
(fr)
|
1994-10-28 |
1996-11-29 |
Centre Nat Rech Scient |
Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
|
|
NZ300387A
(en)
|
1994-12-12 |
2001-07-27 |
Genetic Therapy Inc |
Adenoviral vector modified to reduce host immune and inflammatory responses and its use in gene therapy treatment
|
|
US6127525A
(en)
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
|
US5770442A
(en)
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
|
US20030026789A1
(en)
|
1995-05-03 |
2003-02-06 |
Richard J. Gregory |
Gene therapy using replication competent targeted adenoviral vectors
|
|
US6506379B1
(en)
|
1995-06-07 |
2003-01-14 |
Ariad Gene Therapeutics, Inc. |
Intramuscular delivery of recombinant AAV
|
|
AUPN477695A0
(en)
|
1995-08-14 |
1995-09-07 |
Commonwealth Scientific And Industrial Research Organisation |
Gene therapy
|
|
US5945335A
(en)
|
1995-11-09 |
1999-08-31 |
Avigen, Inc. |
Adenovirus helper-free system for producing recombinant AAV virions lacking oncogenic sequences
|
|
US6083720A
(en)
|
1995-11-13 |
2000-07-04 |
Chroboczek; Jadwiga |
Dodecahedral adenoviral protein complex, composition containing same and uses thereof
|
|
JP3420586B2
(ja)
|
1995-11-28 |
2003-06-23 |
ジェンベク、インコーポレイティッド |
細胞への遣伝子導入のためのベクターおよび方法
|
|
US6133243A
(en)
|
1996-02-22 |
2000-10-17 |
Onyx Pharmaceuticals, Inc. |
Liposomal-viral DNA complexes for treating disease
|
|
FR2746110B1
(fr)
|
1996-03-14 |
1998-04-17 |
|
Methode de traitement par therapie genique des tumeurs humaines et virus recombinants correspondants
|
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
EP0944717A1
(fr)
|
1996-07-01 |
1999-09-29 |
Aventis Pharma S.A. |
Procede de production d'adenovirus recombinants
|
|
WO1998054346A1
(en)
|
1997-05-28 |
1998-12-03 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
US5922315A
(en)
|
1997-01-24 |
1999-07-13 |
Genetic Therapy, Inc. |
Adenoviruses having altered hexon proteins
|
|
US6403370B1
(en)
|
1997-02-10 |
2002-06-11 |
Genstar Therapeutics Corporation |
Oncolytic/immunogenic complementary-adenoviral vector system
|
|
US20050287120A1
(en)
|
1997-03-21 |
2005-12-29 |
Fisher Paul B |
Cancer - targeted viral vectors
|
|
FR2761689B1
(fr)
|
1997-04-02 |
1999-06-25 |
Transgene Sa |
Fibre adenovirale modifiee et adenovirus cibles
|
|
US6200799B1
(en)
|
1997-06-03 |
2001-03-13 |
University Of Lausanne |
Somatic gene therapy to suppress secondary cataract formation following eye surgery
|
|
ATE256196T1
(de)
|
1997-06-09 |
2003-12-15 |
Genvec Inc |
Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
|
|
CN1281512A
(zh)
|
1997-12-12 |
2001-01-24 |
昂尼克斯药物公司 |
p53+肿瘤细胞的选择性杀伤和诊断
|
|
IL137681A0
(en)
|
1998-02-06 |
2001-10-31 |
Uab Research Foundation |
Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
|
|
US6984635B1
(en)
|
1998-02-13 |
2006-01-10 |
Board Of Trustees Of The Leland Stanford Jr. University |
Dimerizing agents, their production and use
|
|
IL137730A0
(en)
|
1998-02-17 |
2001-10-31 |
Uab Research Foundation |
Modified adenovirus containing a fiber replacement protein
|
|
US20050095231A1
(en)
|
1998-02-17 |
2005-05-05 |
Curiel David T. |
Modified adenovirus containing a fiber replacement protein
|
|
AU2796799A
(en)
|
1998-03-03 |
1999-09-20 |
Uab Research Foundation, The |
Amplification of gene transfer and gene therapy by controlled replication
|
|
AU3358999A
(en)
|
1998-03-20 |
1999-10-11 |
Genzyme Corporation |
Chimeric adenoviral vectors for targeted gene delivery
|
|
US7829329B2
(en)
|
1998-04-24 |
2010-11-09 |
Onyx Pharmaceuticals, Inc. |
Adenoviral vectors for treating disease
|
|
US6670188B1
(en)
|
1998-04-24 |
2003-12-30 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
|
ES2210081T3
(es)
|
1998-07-07 |
2004-07-01 |
Transgene S.A. |
Utilizacion de los marcos de lectura de la region e4 para la mejora de la expresion de genes.
|
|
US20030017138A1
(en)
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
|
CA2341061A1
(en)
|
1998-08-27 |
2000-03-09 |
Aventis Pharma S.A. |
Targeted adenovirus vectors for delivery of heterologous genes
|
|
US6900049B2
(en)
|
1998-09-10 |
2005-05-31 |
Cell Genesys, Inc. |
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
|
|
EP1112372A1
(en)
|
1998-09-11 |
2001-07-04 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
US6841540B1
(en)
|
1998-09-29 |
2005-01-11 |
The Uab Research Foundation |
Immunomodulation by genetic modification of dendritic cells and B cells
|
|
HU226602B1
(en)
|
1998-10-15 |
2009-04-28 |
Canji |
Selectively replicating viral vectors, pharmaceutical preparations containing them and process for producing them
|
|
US20020037274A1
(en)
|
1998-10-26 |
2002-03-28 |
Angelica Williams |
Single agent method for killing tumor and tumor associated endothelial cells using adenoviral mutants
|
|
US6929946B1
(en)
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
|
EP1141357A1
(en)
|
1999-01-14 |
2001-10-10 |
Novartis AG |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
US7157266B2
(en)
|
1999-01-25 |
2007-01-02 |
Brookhaven Science Associates Llc |
Structure of adenovirus bound to cellular receptor car
|
|
US6395875B1
(en)
|
1999-01-25 |
2002-05-28 |
Brookhaven Science Associates Llc |
Recombinant soluble adenovirus receptor
|
|
CA2364499C
(en)
|
1999-03-04 |
2008-12-23 |
Introgene B.V. |
Means and methods for fibroblast-like or macrophage-like cell transduction
|
|
US6869936B1
(en)
|
1999-03-04 |
2005-03-22 |
Crucell Holland B.V. |
Means and methods for fibroblast-like or macrophage-like cell transduction
|
|
AU767904B2
(en)
|
1999-05-12 |
2003-11-27 |
Uab Research Foundation, The |
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
|
|
US20040175362A1
(en)
|
1999-05-12 |
2004-09-09 |
Curiel David T. |
Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
|
|
ATE519855T1
(de)
|
1999-05-17 |
2011-08-15 |
Crucell Holland Bv |
Rekombinantes adenovirus des serotyps ad11
|
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
|
US20050232900A1
(en)
|
1999-05-18 |
2005-10-20 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
|
AU5464000A
(en)
|
1999-06-01 |
2000-12-18 |
University Of Washington |
Recombinant adenoviral vectors for cell specific infection and genome integration and expressing chimeric fiber proteins
|
|
EP1593742A3
(en)
|
1999-06-01 |
2006-02-01 |
The University of Washington |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection
|
|
US7094398B1
(en)
|
1999-06-01 |
2006-08-22 |
University Of Washington |
Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
|
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
|
DE19929569A1
(de)
|
1999-06-21 |
2000-12-28 |
Holm Per Sonne |
Mittel zur Behandlung maligner Erkrankungen unter Verwendung des Proteins YB-1
|
|
CA2378324A1
(en)
|
1999-07-06 |
2001-01-11 |
Leif Lindholm |
Recombinant adenovirus
|
|
US7589069B1
(en)
|
1999-07-12 |
2009-09-15 |
Saint Louis University |
Replication-competent anti-cancer vectors
|
|
JP2003508057A
(ja)
|
1999-08-27 |
2003-03-04 |
トランスジェン・ソシエテ・アノニム |
改変アデノウイルスファイバーおよび用途
|
|
WO2001021217A2
(en)
|
1999-09-23 |
2001-03-29 |
Genvec, Inc. |
Method of treating cells of the prostate prophylactically or therapeutically
|
|
WO2001021216A1
(en)
|
1999-09-24 |
2001-03-29 |
The Uab Research Foundation |
Capsid-modified recombinant adenovirus and methods of use
|
|
AU1190901A
(en)
|
1999-09-30 |
2001-04-30 |
Trustees Of The University Of Pennsylvania, The |
Replication selective adenoviruses for use in cancer therapy
|
|
WO2001028569A1
(en)
|
1999-10-15 |
2001-04-26 |
Canji, Inc. |
Targeted vectors
|
|
EP1955703A1
(en)
|
1999-11-12 |
2008-08-13 |
Oncolytics Biotech Inc. |
Viruses for the treatment of cellular proliferative disorders
|
|
ES2288488T3
(es)
|
1999-11-15 |
2008-01-16 |
Onyx Pharmaceuticals, Inc. |
Adenovirus oncoliticos.
|
|
US6867022B1
(en)
|
2000-01-21 |
2005-03-15 |
Regents Of The University Of Michigan |
Replication deficient adenovirus vectors and methods of making and using them
|
|
AU2001234981A1
(en)
|
2000-02-09 |
2001-08-20 |
Genvec, Inc. |
Adenoviral capsid containing chimeric protein ix
|
|
AU2001247648B2
(en)
|
2000-03-24 |
2006-03-30 |
Cold Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
US6911200B2
(en)
|
2000-03-24 |
2005-06-28 |
Cell Genesys, Inc. |
Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation
|
|
US6692736B2
(en)
|
2000-03-24 |
2004-02-17 |
Cell Genesys, Inc. |
Cell-specific adenovirus vectors comprising an internal ribosome entry site
|
|
US20030082146A1
(en)
|
2000-04-26 |
2003-05-01 |
Van Es Helmuth H. G. |
Adenovirus vectors with knobless fibers, and their uses
|
|
WO2001083729A2
(en)
|
2000-05-01 |
2001-11-08 |
Novartis Ag |
Vectors for ocular transduction and use thereof for genetic therapy
|
|
US7332337B2
(en)
|
2000-05-16 |
2008-02-19 |
Galapagos Nv |
Viral vectors having tissue tropism for T-lymphocytes, B- and mast cells
|
|
EP1157999A1
(en)
|
2000-05-24 |
2001-11-28 |
Introgene B.V. |
Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
|
|
WO2001090392A1
(en)
|
2000-05-26 |
2001-11-29 |
Sumitomo Pharmaceuticals Company, Limited |
Novel recombinant adenovirus vector with relieved side effects
|
|
JP2003534805A
(ja)
|
2000-05-31 |
2003-11-25 |
ユニバーシティ オブ サスカチュワン |
変化した親和性を有する改変ウシアデノウイルス
|
|
AU2001265154A1
(en)
|
2000-05-31 |
2001-12-11 |
Genvec, Inc. |
Method and composition for targeting an adenoviral vector
|
|
US7754201B2
(en)
|
2000-06-02 |
2010-07-13 |
GenPhar, Inc |
Method of vaccination through serotype rotation
|
|
EP1167533A1
(en)
|
2000-06-23 |
2002-01-02 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
Methods and means for the complementation of viral protein expression in stable cell lines
|
|
US6579522B1
(en)
|
2000-06-27 |
2003-06-17 |
Genvec, Inc. |
Replication deficient adenoviral TNF vector
|
|
US7022496B2
(en)
|
2000-07-14 |
2006-04-04 |
The Johns Hopkins University |
Use of gene product of adenovirus early region 4 ORF-6 to inhibit repair of double-strand breaks in DNA
|
|
US20020106382A1
(en)
|
2000-07-14 |
2002-08-08 |
Young Charles S.H. |
Modified adenovirus and uses thereof
|
|
GB0017720D0
(en)
|
2000-07-19 |
2000-09-06 |
Got A Gene Ab |
Modified virus
|
|
CA2418977C
(en)
|
2000-08-10 |
2011-01-18 |
Crucell Holland B.V. |
Gene delivery vectors with cell type specificity for primary human chondrocytes
|
|
DE60138403D1
(de)
|
2000-09-26 |
2009-05-28 |
Crucell Holland Bv |
Adenovirale vektoren für die übertragung von genen in zellen der skelettmuskulatur oder myoblasten
|
|
ATE460472T1
(de)
|
2000-12-08 |
2010-03-15 |
Life Technologies Corp |
Verfahren und zusammensetzungen zur synthese von nukleinsäuremolekülen unter verwendung multipler erkennungsstellen
|
|
US20030095989A1
(en)
|
2000-12-18 |
2003-05-22 |
Irving John M. |
Chimeric cytolytic viruses for cancer treatment
|
|
US6635466B2
(en)
|
2001-01-09 |
2003-10-21 |
University Of Iowa Research Foundation |
Adenovirus serotype 30 (Ad30)
|
|
AU2002250081A1
(en)
|
2001-02-14 |
2002-08-28 |
Uab Research Foundation |
Combined transductional and transcriptional targeting system for improved gene delivery
|
|
IL152420A0
(en)
|
2001-02-23 |
2003-05-29 |
Novartis Ag |
Novel oncolytic adenoviral vectors
|
|
WO2002079507A2
(de)
|
2001-04-02 |
2002-10-10 |
Bayer Aktiengesellschaft |
Verfahren zur spezifischen detektion, isolation und charakterisierung von zellen aus körperproben durch transfektion von nukleinsäurekonstrukten
|
|
US20030219899A1
(en)
|
2001-04-17 |
2003-11-27 |
Nikolay Korokhov |
Mosaic adenoviral vectors
|
|
US20030138405A1
(en)
|
2001-04-17 |
2003-07-24 |
Juan Fueyo |
Conditionally replicative adenovirus to target the Rb and Rb-related pathways
|
|
CA2445626A1
(en)
|
2001-04-17 |
2002-10-24 |
Vectorlogics, Inc. |
Mosaic adenoviral vectors
|
|
ES2375557T3
(es)
|
2001-06-22 |
2012-03-02 |
The Trustees Of The University Of Pennsylvania |
Adenovirus recombinantes que comprenden prote�?nas de adenovirus de simios y usos de los mismos.
|
|
US6844192B2
(en)
|
2001-06-29 |
2005-01-18 |
Wake Forest University |
Adenovirus E4 protein variants for virus production
|
|
US6905678B2
(en)
|
2001-07-07 |
2005-06-14 |
Crucell Holland B.V. |
Gene delivery vectors with cell type specificity for mesenchymal stem cells
|
|
EP1409653A4
(en)
|
2001-07-23 |
2006-05-03 |
Onyx Pharma Inc |
IN HUMAN TARGET CANCELLS SELECTIVELY REPLICATING VIRUS MUTANTS
|
|
EP1427816A4
(en)
|
2001-09-18 |
2004-12-01 |
Clontech Lab Inc |
METHOD FOR THE PRODUCTION OF ADENOVIRUS VECTORS, BASED ON A SPECIFIC RECOMBINASE
|
|
US7569217B2
(en)
|
2001-09-24 |
2009-08-04 |
University Of Saskatchewan |
Porcine adenovirus E1 and E4 regions
|
|
EP1446479B1
(en)
|
2001-09-29 |
2012-08-15 |
Chae-Ok Yun |
Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
|
|
EP1453543B1
(en)
|
2001-11-21 |
2017-08-30 |
The Trustees Of The University Of Pennsylvania |
Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
|
|
CN100475966C
(zh)
|
2001-11-23 |
2009-04-08 |
上海三维生物技术有限公司 |
具有肿瘤细胞特异性感染和转基因表达能力的新型腺病毒
|
|
EP1327688A1
(en)
|
2002-01-14 |
2003-07-16 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
Adenoviruses with enhanced lytic potency
|
|
WO2003062400A2
(en)
|
2002-01-24 |
2003-07-31 |
The Scripps Research Institute |
Fiber shaft modifications for efficient targeting
|
|
WO2003064666A1
(en)
|
2002-02-01 |
2003-08-07 |
Transgene S.A. |
Adenoviral vectors for modulating the cellular activities associated with pods
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
US20040005710A1
(en)
|
2002-03-09 |
2004-01-08 |
Ho-Sun Son |
Method for producing recombinant viruses using site-specific recombination
|
|
EP1605053A1
(en)
|
2002-03-26 |
2005-12-14 |
Oncolytics Biotech Inc. |
Use of adenoviruses mutated in the VA genes for cancer treatment
|
|
KR101021387B1
(ko)
|
2002-04-25 |
2011-03-14 |
크루셀 홀란드 비.브이. |
아데노바이러스 벡터를 생산하기 위한 수단 및 방법
|
|
EP1499332A4
(en)
|
2002-04-29 |
2006-12-06 |
Hadasit Med Res Service |
COMPOSITIONS AND METHODS FOR TREATING CANCER WITH A VIRAL ONCOLYTIC AGENT
|
|
EP1504016A4
(en)
|
2002-05-08 |
2006-11-22 |
Intronn Inc |
USE OF SPLICEOSOM-MEDIATED RNA-TRANS-SPLICING TO GIVE ADENOVIRES A CELLSELECTIVE REPLICATION
|
|
CA2487811A1
(en)
|
2002-05-27 |
2003-12-04 |
Per Sonne Holm |
Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors
|
|
US20060228334A1
(en)
|
2002-07-10 |
2006-10-12 |
Manuel Rosa-Calatrava |
Modified adenoviral fiber with ablated to cellular receptors
|
|
JP2005532829A
(ja)
|
2002-07-18 |
2005-11-04 |
インヴィトロジェン コーポレーション |
組換え部位を含むウイルスベクター
|
|
US7364727B2
(en)
|
2002-07-22 |
2008-04-29 |
Cell Genesys, Inc. |
Metastatic colon cancer specific promoter and uses thereof
|
|
EP1539937A4
(en)
|
2002-08-22 |
2006-07-26 |
Merck & Co Inc |
METHOD FOR THE REPRODUCTION OF ADENOVIRUS AND PRODUCT VIRUS THEREWITH
|
|
EP1545627A4
(en)
|
2002-10-01 |
2006-12-27 |
Univ Duke |
TARGETED TUMOR THERAPY THROUGH THE USE OF RECOMBINANT ADENOVIRUS VECTORS FOR SELECTIVE REPLICATION IN HYPOXIC TUMOR REGIONS
|
|
EP1413586A1
(en)
|
2002-10-21 |
2004-04-28 |
Centre National De La Recherche Scientifique (Cnrs) |
Regulation of the Cre recombinase using a dissociation/re-association system of said recombinase
|
|
US20040102382A1
(en)
|
2002-11-27 |
2004-05-27 |
Transgene, S.A. |
Targeting peptides
|
|
WO2004083418A1
(en)
|
2003-03-17 |
2004-09-30 |
Merck & Co., Inc. |
Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
|
|
US20040191761A1
(en)
|
2003-03-27 |
2004-09-30 |
Routes John M. |
Modified adenoviral E1A constructs and methods of use thereof
|
|
JP2006521089A
(ja)
|
2003-03-28 |
2006-09-21 |
メルク エンド カムパニー インコーポレーテッド |
アデノウイルス血清型３４ベクター、核酸及びそれにより生産されるウイルス
|
|
WO2004087930A1
(en)
|
2003-03-28 |
2004-10-14 |
Saint Louis University |
Adenovirus replication-competent vectors expressing trail
|
|
CA2519680A1
(en)
|
2003-03-28 |
2004-11-18 |
The Scripps Research Institute |
Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
|
|
US20050095705A1
(en)
|
2003-04-15 |
2005-05-05 |
Michael Kadan |
Method for production of oncolytic adenoviruses
|
|
US20060281090A1
(en)
|
2003-05-01 |
2006-12-14 |
University Of Washington Uw Tech Transfer- Invention Licensing |
Capsid-modified adenovirus vectors and methods of using the same
|
|
US7611868B2
(en)
|
2003-05-14 |
2009-11-03 |
Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Recombinant modified adenovirus fiber protein
|
|
US20050079158A1
(en)
|
2003-06-05 |
2005-04-14 |
Shenzhen Allucks Biotech Co., Ltd. |
Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
|
|
WO2004108755A2
(en)
|
2003-06-10 |
2004-12-16 |
University Of Saskatchewan |
Chimeric adenovirus capsid proteins
|
|
JP2007531507A
(ja)
|
2003-06-11 |
2007-11-08 |
ザ スクリップス リサーチ インスティテュート |
効率的な受容体結合のための修飾型線維タンパク質
|
|
US7291498B2
(en)
|
2003-06-20 |
2007-11-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
WO2005001103A2
(en)
|
2003-06-20 |
2005-01-06 |
The Trustees Of The University Of Pennsylvania |
Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses
|
|
AU2004260044B2
(en)
|
2003-07-18 |
2009-04-23 |
Onyx Pharmaceuticals, Inc. |
Subgroup B adenoviral vectors for treating disease
|
|
ES2391975T3
(es)
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
|
US20050186178A1
(en)
|
2003-08-28 |
2005-08-25 |
Ennist David L. |
Oncolytic adenoviral vectors encoding GM-CSF
|
|
WO2005030261A1
(en)
|
2003-08-28 |
2005-04-07 |
Cell Genesys, Inc. |
Oncolytic adenoviral vectors encoding gm-csf
|
|
WO2005023848A2
(en)
|
2003-09-09 |
2005-03-17 |
Gardner, Rebecca, Katherine |
Adenoviral epitopes
|
|
US7482156B2
(en)
|
2003-10-15 |
2009-01-27 |
Cell Genesys, Inc. |
Hepatocellular carcinoma specific promoter and uses thereof
|
|
EP1689445B1
(de)
|
2003-11-14 |
2015-02-25 |
Per Sonne Holm |
Neue verwendung von adenoviren und dafür codierende nukleinsäuren
|
|
US20050201978A1
(en)
|
2003-11-17 |
2005-09-15 |
Lipton James S. |
Tumor and infectious disease therapeutic compositions
|
|
WO2005065348A2
(en)
|
2003-12-31 |
2005-07-21 |
Kalobios, Inc. |
Transactivation system for mammalian cells
|
|
WO2005075506A1
(en)
|
2004-01-09 |
2005-08-18 |
The Scripps Research Institute |
Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors
|
|
ATE449105T1
(de)
|
2004-01-23 |
2009-12-15 |
Angeletti P Ist Richerche Bio |
Impfstoffträger für schimpansen-adenovirus
|
|
US20050201936A1
(en)
|
2004-02-12 |
2005-09-15 |
Wold William S.M. |
Models for viral-based cancer therapy
|
|
WO2005086922A2
(en)
|
2004-03-10 |
2005-09-22 |
Board Of Regents, University Of Texas System |
Oncolytic adenovirus armed with therapeutic genes
|
|
US7473418B2
(en)
|
2004-03-25 |
2009-01-06 |
Cell Genesys, Inc. |
Pan cancer oncolytic vectors and methods of use thereof
|
|
CN1968717B
(zh)
|
2004-03-30 |
2013-08-21 |
延世大学教产学协力团 |
含有松弛素基因的基因送递系统和使用松弛素的药物组合物
|
|
WO2005107474A2
(en)
|
2004-04-30 |
2005-11-17 |
Introgen Therapeutics, Inc. |
Oncolytic adenovirus armed with therapeutic genes
|
|
EP1743041B1
(en)
|
2004-05-03 |
2012-06-27 |
Stefan Kochanek |
Modified viral vector particles
|
|
GB0411428D0
(en)
|
2004-05-21 |
2004-06-23 |
Got A Gene Ab |
Vectors
|
|
US7510868B2
(en)
|
2004-05-26 |
2009-03-31 |
Paul Harden |
Chimeric adenoviruses for use in cancer treatment
|
|
US20050271622A1
(en)
|
2004-06-03 |
2005-12-08 |
Shenzhen Allucks Biotech Co., Ltd. |
Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
|
|
WO2005117993A2
(en)
|
2004-06-04 |
2005-12-15 |
Genvec, Inc. |
Method of using adenoviral vectors with improved safety and efficacy for the treatment of cancer
|
|
CN100361710C
(zh)
|
2004-06-07 |
2008-01-16 |
成都康弘生物科技有限公司 |
肿瘤细胞专一表达免疫调节因子gm-csf的溶瘤性腺病毒重组体的构建及其应用
|
|
US20060292682A1
(en)
|
2004-07-22 |
2006-12-28 |
Hawkins Lynda K |
Addition of transgenes into adenoviral vectors
|
|
GB0416487D0
(en)
|
2004-07-23 |
2004-08-25 |
Isis Innovation |
Modified virus
|
|
US7776322B2
(en)
|
2004-08-16 |
2010-08-17 |
Stefan Kochanek |
Modified viral vector particles
|
|
WO2006039045A2
(en)
|
2004-09-01 |
2006-04-13 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
|
US7943373B2
(en)
|
2004-09-29 |
2011-05-17 |
Oncolys Biopharma, Inc. |
Telomelysin/GFP-expressing recombinant virus
|
|
BRPI0516048A
(pt)
|
2004-10-13 |
2008-08-19 |
Crucell Holland B V E Beth Isr |
batelada de um adenovìrus recombinante defectivo em replicação baseado em um sorotipo do subgrupo c
|
|
US20070122817A1
(en)
|
2005-02-28 |
2007-05-31 |
George Church |
Methods for assembly of high fidelity synthetic polynucleotides
|
|
RU2007119313A
(ru)
|
2004-10-25 |
2008-11-27 |
Новартис АГ (CH) |
Полинуклеотиды и полипептиды torc и способы применения
|
|
IL166049A0
(en)
|
2004-12-30 |
2006-01-15 |
Gavish Galilee Bio Appl Ltd |
Method for obtaining modified proteins and viruseswith intact native binding
|
|
EP1830864A2
(de)
|
2004-12-31 |
2007-09-12 |
Per Sonne Holm |
E1 -minus adenoviren und deren verwendung
|
|
JP5584393B2
(ja)
|
2004-12-31 |
2014-09-03 |
ホルム，ペル・ゾンネ |
動物細胞における多剤耐性を逆転させる方法
|
|
WO2006086357A2
(en)
|
2005-02-10 |
2006-08-17 |
Merck & Co., Inc. |
Adenovirus serotype 36 vectors, nucleic acid and viruses produced thereby
|
|
JP2008538894A
(ja)
|
2005-02-11 |
2008-11-13 |
メルク エンド カムパニー インコーポレーテッド |
アデノウイルス血清型２６ベクター、核酸およびそれにより製造されたウイルス
|
|
KR100747646B1
(ko)
|
2005-02-25 |
2007-08-08 |
연세대학교 산학협력단 |
데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물
|
|
WO2006119449A2
(en)
|
2005-05-04 |
2006-11-09 |
Vectorlogics, Inc. |
Modified adenovirus containing a stabilized antibody
|
|
WO2007050128A2
(en)
|
2005-05-31 |
2007-05-03 |
Vectorlogics, Inc. |
Shielded adenoviral vectors and methods of use
|
|
WO2006133911A2
(en)
|
2005-06-17 |
2006-12-21 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Hepatitis c virus nucleic acid vaccine
|
|
AU2006284756B2
(en)
|
2005-08-31 |
2012-06-07 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
KR100723009B1
(ko)
|
2005-11-30 |
2007-05-29 |
한국원자력연구원 |
인간 ｐ３１ 유전자를 함유하는 악성 종양 치료용 약학적조성물
|
|
ES2304281B1
(es)
|
2006-02-01 |
2009-08-12 |
Dnatrix Inc. |
Adenovirus oncoliticos para el tratamiento del cancer.
|
|
WO2007094653A1
(en)
|
2006-02-13 |
2007-08-23 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles.
|
|
US20070292396A1
(en)
|
2006-03-02 |
2007-12-20 |
Juan Fueyo |
Combination therapy with oncolytic adenovirus
|
|
US20070292954A1
(en)
|
2006-04-21 |
2007-12-20 |
The Brigham And Women's Hospital, Inc. |
Generation of recombinant DNA by sequence-and ligation-independent cloning
|
|
CN101437538A
(zh)
|
2006-04-28 |
2009-05-20 |
宾夕法尼亚州立大学托管会 |
修饰的腺病毒六邻体蛋白和其应用
|
|
US20080242608A1
(en)
|
2006-06-02 |
2008-10-02 |
Azad Bonni |
Methods and compositions for treating and preventing neurologic disorders
|
|
EP2041291A1
(en)
|
2006-06-19 |
2009-04-01 |
Institut Gustave Roussy |
Inhibition of the liver tropism of adenoviral vectors
|
|
JP2008048621A
(ja)
|
2006-08-22 |
2008-03-06 |
Chiba Prefecture |
キメラ型アデノウイルスとその作製方法並びにそれを用いた医薬
|
|
GR20060100496A
(el)
|
2006-09-01 |
2008-04-15 |
Παρθενιος Μπουλικας |
ΛΙΠΟΣΩΜΑΤΙΚΑ ΕΓΚΑΨΥΛΙΩΜΕΝΟΙ ΦΟΡΕΙΣ-ΥΒΡΙΔΙΟΥ ΑΔΕΝΟΙΟΥ - ΙΟΥ SEMLIKI FOREST (SFV), ΠΟΥ ΦΕΡΕΙ ΚΑΤΑΣΚΕΥΑΣΜΑΤΑ RNAi ΚΑΙ ΘΕΡΑΠΕΥΤΙΚΑ ΓΟΝΙΔΙΑ ΠΟΥ ΧΡΗΣΙΜΟΠΟΙΟΥΝΤΑΙ ΕΝΑΝΤΙΟΝ ΣΤΟΧΩΝ ΚΑΡΚΙΝΟΥ ΚΑΙ ΑΛΛΩΝ ΑΣΘΕΝΕΙΩΝ
|
|
WO2008067025A2
(en)
|
2006-09-29 |
2008-06-05 |
Evanston Northwestern Healthcare |
Oncolytic adenoviruses and uses thereof
|
|
WO2008140474A1
(en)
|
2006-10-26 |
2008-11-20 |
Johns Hopkins University |
Recombinant adenovirus vaccines
|
|
EP2118102B1
(en)
|
2006-11-28 |
2013-06-12 |
Nerviano Medical Sciences S.r.l. |
Tricyclic indoles and (4,5-dihydro) indoles
|
|
WO2008095168A2
(en)
|
2007-02-01 |
2008-08-07 |
University Of Chicago |
Compositions and methods related to a recombinant adenoviral vector that targets il 13 receptors
|
|
ATE510907T1
(de)
|
2007-03-14 |
2011-06-15 |
Inst Catala D Oncologia |
Adenovirus mit mutationen in der domäne des e3- 19k-proteins zur retention im endoplasmatischen retikulum und verwendung in der krebsbehandlung
|
|
WO2008150496A2
(en)
|
2007-05-31 |
2008-12-11 |
Genelux Corporation |
Assay for sensitivity to chemotherapeutic agents
|
|
WO2009065800A1
(en)
|
2007-11-20 |
2009-05-28 |
Crucell Holland B.V. |
Recombinant human adenoviruses for eliciting mucosal immune responses
|
|
CA2706257C
(en)
|
2007-11-28 |
2017-06-06 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily b adenovirus sadv-28, -27, -29, -32, -33 and -35 and uses thereof
|
|
EP2463362B1
(en)
|
2007-11-28 |
2017-11-08 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily c adenovirus SAdv-31 and uses thereof
|
|
MX2010005858A
(es)
|
2007-11-28 |
2010-06-11 |
Univ Pennsylvania |
Adenovirus e simianos sadv-39, sadv-25.2, sadv-26, sadv-30, sadv-37 y sadv-38.
|
|
CN102014948A
(zh)
|
2008-02-07 |
2011-04-13 |
安德鲁·贝克 |
腺病毒向性的调节
|
|
CA2716928C
(en)
|
2008-03-04 |
2018-04-10 |
The Trustees Of The University Of Pennsylvania |
Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof
|
|
WO2009117656A2
(en)
|
2008-03-21 |
2009-09-24 |
Vectorlogics,Inc. |
Capsid-incorporated antigen for novel adenovirus vaccine
|
|
US20110086063A1
(en)
|
2008-06-04 |
2011-04-14 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
JP5596026B2
(ja)
|
2008-06-19 |
2014-09-24 |
ミレニアム ファーマシューティカルズ， インコーポレイテッド |
チオフェン又はチアゾール誘導体及びｐｉ３ｋ阻害剤としてのそれらの使用
|
|
KR101034811B1
(ko)
|
2008-08-25 |
2011-05-16 |
단국대학교 산학협력단 |
조직 특이적 프로모터와 암 특이 유전자를 타겟팅하는트랜스-스플라이싱 라이보자임을 포함하는 재조합아데노바이러스 및 이의 용도
|
|
US8808986B2
(en)
|
2008-08-27 |
2014-08-19 |
Gen9, Inc. |
Methods and devices for high fidelity polynucleotide synthesis
|
|
JP2012504140A
(ja)
|
2008-09-26 |
2012-02-16 |
オーバーン・ユニバーシティ |
非複製性ベクターワクチンの粘膜投与による鳥類の免疫処置
|
|
US8940290B2
(en)
|
2008-10-31 |
2015-01-27 |
The Trustees Of The University Of Pennsylvania |
Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof
|
|
US9345787B2
(en)
|
2008-12-22 |
2016-05-24 |
Targovax Oy |
Adenoviral vectors and methods and uses related thereto
|
|
HRP20170165T1
(hr)
|
2008-12-22 |
2017-04-07 |
Targovax Oy |
Onkolitički adenovirusni vektori i metode i uporabe u vezi s time
|
|
EP2391638B1
(en)
|
2009-02-02 |
2018-06-27 |
GlaxoSmithKline Biologicals SA |
Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
|
|
KR102020018B1
(ko)
|
2009-03-02 |
2019-09-09 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
종양 선택적 ｅ１ａ 및 ｅ１ｂ 돌연변이
|
|
ES2385251B1
(es)
|
2009-05-06 |
2013-05-06 |
Fundació Privada Institut D'investigació Biomèdica De Bellvitge |
Adenovirus oncolíticos para el tratamiento del cáncer.
|
|
CN102575232B
(zh)
|
2009-05-29 |
2015-07-22 |
宾夕法尼亚大学托管会 |
猿腺病毒41及其应用
|
|
CN102549152B
(zh)
|
2009-07-31 |
2015-11-25 |
帕克斯瓦克斯股份有限公司 |
基于腺病毒的载体
|
|
WO2011022002A1
(en)
|
2009-08-18 |
2011-02-24 |
The Rockefeller University |
Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
|
|
US9555089B2
(en)
|
2009-08-18 |
2017-01-31 |
The Rockefeller University |
Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
|
|
KR101248912B1
(ko)
|
2009-12-31 |
2013-03-29 |
한양대학교 산학협력단 |
항혈관신생 활성을 가지는 재조합 아데노바이러스
|
|
US9163261B2
(en)
|
2010-02-22 |
2015-10-20 |
Koteswara Rao KOLLIPARA |
Adeno-associated virus 2/8—micro RNA-101 therapy for liver cancer
|
|
CN102191245B
(zh)
|
2010-03-15 |
2013-11-13 |
浙江东方基因生物制品有限公司 |
应用肿瘤特异性启动子表达报告基因来检测循环血中肿瘤细胞的方法和试剂
|
|
ES2887335T3
(es)
|
2010-03-17 |
2021-12-22 |
Univ Cornell |
Vacuna contra las drogas de abuso basada en adenovirus alterado
|
|
US20130058897A1
(en)
|
2010-04-14 |
2013-03-07 |
Mogam Biotechnology Research Institute |
Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
|
|
WO2011133040A2
(en)
|
2010-04-23 |
2011-10-27 |
Orca Therapeutics B.V. |
Replication-competent adenoviruses
|
|
KR101497035B1
(ko)
|
2010-04-26 |
2015-02-27 |
주식회사 녹십자 |
종양 특이적 프로모터 및 이를 포함하는 종양살상 바이러스 벡터
|
|
KR20180122043A
(ko)
|
2010-06-10 |
2018-11-09 |
유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 |
데스모글레인 2(디에스쥐2)와 아데노바이러스의 상호작용을 위한 방법 및 시스템
|
|
US20140017668A1
(en)
|
2010-06-30 |
2014-01-16 |
The Johns Hopkins University |
COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING CIRCULATING TUMOR CELLS (CTCs)
|
|
SG187785A1
(en)
|
2010-08-16 |
2013-03-28 |
Salk Inst For Biological Studi |
Anti-cancer adenoviruses
|
|
WO2012024351A2
(en)
|
2010-08-16 |
2012-02-23 |
Salk Institute For Biological Studies |
Adenoviral assembly method
|
|
WO2012022496A2
(en)
|
2010-08-19 |
2012-02-23 |
Per Sonne Holm |
Method for killing tumor stem cells
|
|
KR20130108371A
(ko)
|
2010-09-24 |
2013-10-02 |
온코스 테라퓨틱스 오와이 |
단클론 항―ｃｔｌａ－４ 항체를 암호화하는 종양분해 아데노바이러스 벡터
|
|
RU2013118724A
(ru)
|
2010-09-24 |
2014-10-27 |
Онкос Терапьютикс Ой |
Онколитические аденовирусные векторы и связанные с ними способы и применения
|
|
WO2012071318A2
(en)
|
2010-11-23 |
2012-05-31 |
The Trustees Of The University Of Pennsylvania |
Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof
|
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
|
CN102174479B
(zh)
|
2011-03-02 |
2013-04-03 |
北京锤特生物科技有限公司 |
靶向性治疗人肿瘤的溶肿瘤腺病毒及其应用
|
|
WO2012132369A1
(ja)
|
2011-03-25 |
2012-10-04 |
国立大学法人鹿児島大学 |
癌幹細胞を標的とするウイルスベクター
|
|
US20140341857A1
(en)
|
2011-05-16 |
2014-11-20 |
Institut Gustave Roussy |
Combination of oncolytic adenoviruses with histone deacetylase inhibitors
|
|
US20140377295A1
(en)
|
2011-05-23 |
2014-12-25 |
The Wistar Institute Of Anatomy And Biology |
Influenza vaccines containing modified adenovirus vectors
|
|
GB201108879D0
(en)
|
2011-05-25 |
2011-07-06 |
Isis Innovation |
Vector
|
|
CN102260712B
(zh)
|
2011-05-31 |
2013-10-02 |
北京锤特生物科技有限公司 |
溶肿瘤能力增强的B型人腺病毒Ad11突变体的构建和应用
|
|
KR101946666B1
(ko)
|
2011-08-23 |
2019-02-11 |
고쿠리츠 켄큐 카이하츠 호진 이야쿠 키반 켄코 에이요 켄큐쇼 |
제한 증식형 아데노바이러스
|
|
WO2013036791A2
(en)
|
2011-09-09 |
2013-03-14 |
Beth Israel Deaconess Medical Center, Inc. |
Modified adenoviral vectors and methods of treatment using same
|
|
US8859256B2
(en)
*
|
2011-10-05 |
2014-10-14 |
Genelux Corporation |
Method for detecting replication or colonization of a biological therapeutic
|
|
US9629906B2
(en)
|
2011-10-05 |
2017-04-25 |
Genvec, Inc. |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use
|
|
FI123955B
(en)
|
2011-11-25 |
2014-01-15 |
Oncos Therapeutics Ltd |
Oncolytic adenovirus
|
|
WO2013090806A2
(en)
|
2011-12-15 |
2013-06-20 |
Washington University |
Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
|
|
CN104271748B9
(zh)
*
|
2012-02-02 |
2019-05-24 |
得克萨斯州大学系统董事会 |
表达异源肿瘤相关抗原的腺病毒
|
|
JP5770952B2
(ja)
|
2012-03-12 |
2015-08-26 |
クルセル ホランド ベー ヴェー |
改変末端を有する組換えアデノウイルスのバッチ
|
|
CA3215250A1
(en)
|
2012-03-13 |
2013-09-19 |
Salk Institute For Biological Studies |
Selective cell targeting using adenovirus and chemical dimers
|
|
EP2825889A4
(en)
|
2012-03-14 |
2015-10-28 |
Salk Inst For Biological Studi |
ADENOVIRAL TUMOR DIAGNOSIS
|
|
US9017672B2
(en)
|
2012-05-11 |
2015-04-28 |
Immunicum Aktiebolag |
Hexon Tat-PTD modified adenovirus and uses thereof
|
|
WO2013173702A2
(en)
|
2012-05-18 |
2013-11-21 |
The Trustees Of The University Of Pennsylvania |
Subfamily e simian adenoviruses a1302, a1320, a1331 and a1337 and uses thereof
|
|
JP6162224B2
(ja)
|
2012-05-24 |
2017-07-12 |
クルセル ホランド ベー ヴェー |
血管組織の形質導入のためのアデノウイルスベクター
|
|
WO2013181128A1
(en)
|
2012-05-29 |
2013-12-05 |
Genvec, Inc. |
Modified serotype 28 adenoviral vectors
|
|
AU2013203696A1
(en)
*
|
2012-06-25 |
2014-01-16 |
University Of Canberra |
Recombinant Viral Vectors and Uses Therefor
|
|
EP2900818B1
(en)
|
2012-09-25 |
2017-06-07 |
University of Washington through its Center for Commercialization |
Desmoglein 2 (dsg2) binding proteins and uses therefor
|
|
KR101429696B1
(ko)
|
2012-11-21 |
2014-08-13 |
국립암센터 |
안전성 및 항암활성이 증가된 재조합 아데노바이러스 및 이의 용도
|
|
SG11201506624SA
(en)
|
2013-02-28 |
2015-09-29 |
Psioxus Therapuetics Ltd |
A process for the production of adenovirus
|
|
WO2014160475A1
(en)
|
2013-03-13 |
2014-10-02 |
Aboody Karen S |
Tropic cell based virotherapy for the treatment of cancer
|
|
AU2014236207B2
(en)
|
2013-03-14 |
2019-05-23 |
Salk Institute For Biological Studies |
Oncolytic adenovirus compositions
|
|
ES3011466T3
(en)
|
2013-04-18 |
2025-04-07 |
Tilt Biotherapeutics Oy |
Enhanced adoptive cell therapy
|
|
CA2915973A1
(en)
|
2013-06-18 |
2014-12-24 |
Dnatrix, Inc. |
Treatment of brain cancer with oncolytic adenovirus
|
|
CA2925487C
(en)
|
2013-09-24 |
2023-11-07 |
University Of Washington Through Its Center For Commercialization |
Desmoglein 2 (dsg2) binding proteins and uses therefore in treating disorders associated with epithelial tissues
|
|
CA2931322A1
(en)
|
2013-11-22 |
2015-05-28 |
Dnatrix, Inc. |
Adenovirus expressing immune cell stimulatory receptor agonist(s)
|
|
GB201415579D0
(en)
|
2014-09-03 |
2014-10-15 |
Psioxus Therapeutics Ltd |
A process
|
|
GB201406608D0
(en)
*
|
2014-04-12 |
2014-05-28 |
Psioxus Therapeutics Ltd |
Virus
|
|
EP2940128A1
(en)
|
2014-04-30 |
2015-11-04 |
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Adenovirus comprising an albumin-binding moiety
|
|
JP6705755B2
(ja)
|
2014-05-19 |
2020-06-03 |
バロ セラピューティクス オイＶａｌｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｏｙ |
癌ワクチン開発のための改変アデノウイルス
|
|
EP3150706B1
(en)
|
2014-05-28 |
2019-07-10 |
National University Corporation Okayama University |
Conditionally replicating adenovirus to express reic gene
|
|
KR20250081944A
(ko)
|
2014-09-24 |
2025-06-05 |
솔크 인스티튜트 포 바이올로지칼 스터디즈 |
종양 살상 바이러스 및 이의 사용방법
|
|
WO2016106178A1
(en)
|
2014-12-24 |
2016-06-30 |
The Uab Research Foundation, Inc. |
Multitargeting onocolytic adenovirus, methods of use, and methods of making
|
|
EP3247807B1
(en)
|
2015-01-20 |
2020-12-16 |
Adcure Biotechnologies, LLC. |
Detargeted adenovirus variants and related methods
|
|
WO2016141073A1
(en)
|
2015-03-02 |
2016-09-09 |
Washington University |
Induction of pacemaker-like cells from cardiomyocytes
|
|
CN121592718A
(zh)
|
2015-03-17 |
2026-03-03 |
倾斜生物医疗公司 |
编码双特异性抗体的溶瘤腺病毒及与其相关的方法和用途
|
|
EP3072900A1
(en)
|
2015-03-27 |
2016-09-28 |
Medizinische Hochschule Hannover |
Anti-tumour medicament based on adenovirus
|
|
GB201505860D0
(en)
|
2015-04-07 |
2015-05-20 |
Agalimmune Ltd |
Therapeutic compositions and methods of use for treating cancer
|
|
GB201513176D0
(en)
|
2015-07-27 |
2015-09-09 |
Glaxosmithkline Biolog Sa |
Novel methods for inducing an immune response
|
|
EP3329934B1
(en)
|
2015-09-01 |
2021-03-24 |
Genemedicine Co., Ltd. |
Antitumor immunity enhancing composition containing adenovirus simultaneously expressing il-12 and shvegf
|
|
EP3359175B1
(en)
|
2015-10-05 |
2020-09-16 |
Salk Institute for Biological Studies |
Synthetic adenoviruses with tropism to damaged tissue for use in promoting wound repair and tissue regeneration
|
|
JP6954648B2
(ja)
|
2015-10-19 |
2021-10-27 |
シージー オンコロジー， インコーポレイテッド |
併用療法による固形腫瘍又はリンパ系腫瘍の治療方法
|
|
US11246896B2
(en)
|
2015-10-28 |
2022-02-15 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Tumor-specific adenovirus vectors and therapeutic uses
|
|
WO2017147265A1
(en)
|
2016-02-23 |
2017-08-31 |
Salk Institute For Biological Studies |
High throughput assay for measuring adenovirus replication kinetics
|
|
EP4155411A1
(en)
|
2016-02-23 |
2023-03-29 |
Salk Institute for Biological Studies |
Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
|
|
PL3426271T3
(pl)
|
2016-03-10 |
2025-11-24 |
Cg Oncology, Inc. |
Sposoby leczenia guzów litych terapią skojarzoną
|
|
US20170314044A1
(en)
|
2016-05-02 |
2017-11-02 |
Regents Of The University Of Minnesota |
Adenovirus constructs and methods
|
|
WO2017205423A1
(en)
|
2016-05-23 |
2017-11-30 |
Washington University |
Pulmonary targeted cas9/crispr for in vivo editing of disease genes
|
|
EP3463405A4
(en)
|
2016-05-27 |
2020-02-26 |
DNAtrix, Inc. |
Adenovirus and immunomodulator combination therapy
|
|
GB2549809C
(en)
|
2016-06-23 |
2022-11-30 |
Univ Oxford Innovation Ltd |
Vector
|
|
WO2018064523A1
(en)
|
2016-09-30 |
2018-04-05 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into t cells
|
|
FI20165814A7
(fi)
|
2016-10-27 |
2018-04-28 |
Tilt Biotherapeutics Oy |
Interleukiini 8 (il-8) prognostisena ja ennustavana biomarkkerina ja koostumukset ja vektorit käytettäväksi onkolyyttisessa immunoterapiassa
|
|
US20190275092A1
(en)
|
2016-11-01 |
2019-09-12 |
Dnatrix, Inc. |
Combination therapy for treatment of brain cancers
|
|
WO2018083257A1
(en)
|
2016-11-03 |
2018-05-11 |
Psioxus Therapeutics Limited |
Oncolytic adenovirus encoding transgenes
|
|
WO2018083259A1
(en)
|
2016-11-03 |
2018-05-11 |
Psioxus Therapeutics Limited |
Oncolytic adenovirus encoding transgenes
|
|
WO2018083258A1
(en)
|
2016-11-03 |
2018-05-11 |
Psioxus Therapeutics Limited |
Oncolytic adenovirus encoding at least three transgenes
|
|
WO2018091151A1
(en)
|
2016-11-17 |
2018-05-24 |
Vcn Biosciences Sl |
Use of viral vectors in the treatment of retinoblastoma
|
|
CA3045976A1
(en)
|
2016-12-09 |
2018-06-14 |
Glaxosmithkline Biologicals Sa |
Chimpanzee adenovirus constructs with lyssavirus antigens
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
EP3532082A4
(en)
|
2016-12-12 |
2020-08-26 |
Salk Institute for Biological Studies |
SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES
|
|
US10232053B2
(en)
|
2016-12-30 |
2019-03-19 |
Trieza Therapeutics, Inc. |
Immunomodulatory oncolytic adenoviral vectors, and methods of production and use thereof for treatment of cancer
|
|
WO2018125970A1
(en)
|
2016-12-30 |
2018-07-05 |
Salk Institute For Biological Studies |
Synthetic adenoviruses targeting bone tissue and uses thereof
|
|
JP2020505049A
(ja)
|
2017-01-30 |
2020-02-20 |
エピセントアールエックス，インコーポレイテッド |
複数トランスジーン組み換えアデノウイルス
|
|
JP7242534B2
(ja)
|
2017-01-30 |
2023-03-20 |
エピセントアールエックス，インコーポレイテッド |
腫瘍選択的なｔａｔａボックスおよびｃａａｔボックスの変異体
|
|
AU2018253088B2
(en)
|
2017-04-10 |
2024-09-19 |
Epicentrx, Inc. |
Method for producing recombinant virus
|
|
EA201990822A1
(ru)
|
2017-04-12 |
2020-01-09 |
Эписентарикс, Инк. |
Иммуномодулирующие слитые белки
|
|
US11896634B2
(en)
|
2017-04-21 |
2024-02-13 |
Baylor College Of Medicine |
Oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing immunomodulatory molecules
|
|
WO2018201017A1
(en)
|
2017-04-27 |
2018-11-01 |
Washington University |
Dendritic cell targeted adenovirus for vaccination
|
|
WO2018204677A1
(en)
|
2017-05-04 |
2018-11-08 |
Epicentrx, Inc. |
Oncolytic adenovirus formulation
|
|
US20200155625A1
(en)
|
2017-05-24 |
2020-05-21 |
Epicentrx, Inc. |
Anti-angiogenic adenovirus
|
|
AU2018287317B2
(en)
|
2017-06-19 |
2024-06-20 |
Medicenna Therapeutics Inc. |
Uses and methods for IL-2 superagonists, agonists, and fusions thereof
|
|
WO2019016756A1
(en)
|
2017-07-21 |
2019-01-24 |
Glaxosmithkline Biologicals Sa |
ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES
|
|
DK3460052T3
(da)
|
2017-09-20 |
2020-02-03 |
Immunicum Ab |
Forbedrede allogene dendrittiske celler til anvendelse i behandling af cancer
|
|
WO2019073059A1
(en)
|
2017-10-12 |
2019-04-18 |
Freeline Therapeutics Limited |
ADENOVIRAL AUXILIARY VIRUSES WITH DEFECTIVE CYCLE LIFE, PRODUCTION AND USE FOR THE PRODUCTION OF RAAV
|
|
MA50502A
(fr)
|
2017-10-31 |
2020-09-09 |
Janssen Vaccines & Prevention Bv |
Adénovirus et utilisations associées
|
|
WO2019086450A1
(en)
|
2017-10-31 |
2019-05-09 |
Janssen Vaccines & Prevention B.V. |
Adenovirus and uses thereof
|
|
BR112020008435A2
(pt)
|
2017-10-31 |
2020-11-17 |
Janssen Vaccines & Prevention B.V. |
vetores de adenovírus e seus usos
|
|
WO2019086466A1
(en)
|
2017-10-31 |
2019-05-09 |
Janssen Vaccines & Prevention B.V. |
Adenovirus and uses thereof
|
|
GB201802539D0
(en)
|
2018-02-16 |
2018-04-04 |
Univ College Cardiff Consultants Ltd |
Modified adenoviruses
|
|
GB201804468D0
(en)
|
2018-03-21 |
2018-05-02 |
Valo Therapeutics Oy |
PeptiCRAd Cancer Therapy
|
|
GB201804473D0
(en)
|
2018-03-21 |
2018-05-02 |
Valo Therapeutics Oy |
Modified oncolytic adenoviruses
|
|
US12295976B2
(en)
|
2018-03-28 |
2025-05-13 |
Epicentrx, Inc. |
Personalized cancer vaccines
|
|
MX2020010499A
(es)
|
2018-04-09 |
2020-10-28 |
Salk Inst For Biological Studi |
Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion.
|
|
TW202011977A
(zh)
|
2018-04-20 |
2020-04-01 |
貝勒醫學院 |
溶瘤病毒療法及免疫療法
|
|
JP2021526831A
(ja)
|
2018-06-12 |
2021-10-11 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
アデノウイルスポリヌクレオチド及びポリペプチド
|
|
WO2020014539A1
(en)
|
2018-07-11 |
2020-01-16 |
Epicentrx, Inc. |
Methods and compositions for targeting cancer cells for treatment
|
|
US12233096B2
(en)
|
2018-08-31 |
2025-02-25 |
Orca Therapeutics B.V. |
Recombinant replication competent viruses comprising a coding region for glycogen synthase kinase-3 (GSK3) and methods of killing aberrant cells
|
|
US20210324415A1
(en)
|
2018-10-09 |
2021-10-21 |
Nikegen, Llc |
Compositions and methods for preparing viral vectors
|